MedTrace Logo

Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study

NCT06505577 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-04-06

No results posted yet for this study

Summary

Breast cancer, the most prevalent malignancy among women globally, is increasing in incidence. While non-metastatic breast cancer requires surgery, determining the optimal extent of resection remains challenging. Inadequate resection margins necessitate reoperation, leading to increased psychological stress, costs, and potentially compromised cosmetic outcomes and prognosis.

Accurate preoperative assessment of resection extent is crucial and involves various factors, including imaging studies, physical examinations, tumor molecular subtypes, and intraductal carcinoma components. This prospective observational study aims to identify and integrate multiple predictive factors to enhance surgical planning and minimize reoperation rates in breast cancer patients.

Conditions

  • Mastectomy
  • Breast Neoplasm Malignant Primary

Interventions

OTHER

No additional intervention

All patients are scheduled to undergo standard breast surgery as part of their routine clinical care. No additional interventions are administered specifically for this study.

Sponsors & Collaborators

  • Yonsei University

    collaborator OTHER

  • Incheon St.Mary's Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2026-08-30
Completion
2027-08-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06505577 on ClinicalTrials.gov